Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

WST holding history

West Pharmaceutical Services Inc in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overviewAll 13F holders of WSTFull Q2 2026 holdings

Shares (Q2 2026)
6,581
Value
$2.36M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of WST by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,581$2.36M<0.1%+322+5.1%AddedHolders
Q1 20266,259$1.57M<0.1%−10,370−62.4%ReducedHolders
Q4 202516,629$4.57M<0.1%−12,839−43.6%ReducedHolders
Q3 202529,468$7.12M<0.1%+15,392+109.3%AddedHolders
Q2 202514,076$3.08M<0.1%−778−5.2%ReducedHolders
Q1 202514,854$3.32M<0.1%+6,951+88.0%AddedHolders
Q4 20247,903$1.66M<0.1%+760+10.6%AddedHolders
Q3 20247,143$2.14M<0.1%−220−3.0%ReducedHolders
Q2 20247,363$2.43M<0.1%−385,988−98.1%ReducedHolders
Q1 2024393,351$155.7M0.2%−179,520−31.3%ReducedHolders
Q4 2023572,871$201.7M0.2%−7,910−1.4%ReducedHolders
Q3 2023580,781$217.9M0.3%−2,551−0.4%ReducedHolders
Q2 2023583,332$223.1M0.3%+7,322+1.3%AddedHolders
Q1 2023576,010$199.5M0.2%+87,948+18.0%AddedHolders
Q4 2022488,062$114.9M0.1%+370,589+315.5%AddedHolders
Q3 2022117,473$28.9M<0.1%+68,476+139.8%AddedHolders
Q2 202248,997$14.8M<0.1%−16,440−25.1%ReducedHolders
Q1 202265,437$26.9M<0.1%−3,113−4.5%ReducedHolders
Q4 202168,550$32.2M<0.1%+7,247+11.8%AddedHolders
Q3 202161,303$26.0M<0.1%−7,654−11.1%ReducedHolders
Q2 202168,957$24.8M<0.1%−789−1.1%ReducedHolders
Q1 202169,746$19.7M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.